Drugs that contain Lapatinib Ditosylate
1. Drug name - TYKERB
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents protects the active chemical substance. Only patent owner can launch products that use this active substance. | ||||
| US8821927 | NOVARTIS | Pharmaceutical composition |
Sep, 2029
(6 years from now) | |
| CN101203211A | NOVARTIS | Medicine Composition |
Apr, 2026
(3 years from now) | |
| CN101203211B | NOVARTIS | Drug Composition |
Apr, 2026
(3 years from now) | |
| EP1871347A1 | NOVARTIS | Pharmaceutical Composition |
Apr, 2026
(3 years from now) | |
| EP1871347A4 | NOVARTIS | Pharmaceutical Composition |
Apr, 2026
(3 years from now) | |
| EP1871347B1 | NOVARTIS | Pharmaceutical Composition |
Apr, 2026
(3 years from now) | |
Treatment: NA
Dosage: TABLET;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| EQ 250MG BASE | TABLET;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.